Erleada
Active Ingredient(s): ApalutamideFDA Approved: * February 14, 2018
Pharm Company: * JANSSEN BIOTECH
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Erleada Overview
Apalutamide, sold under the brand name Erleada among others, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer.[2][5][6][7][8] It is specifically indicated for use in conjunction with castration in the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC).[2][9][10] It is taken by mouth.[2&...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Apalutamide
Recent Erleada Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Apalutamide
- Tablet: 60mg
NDC Database Records for Erleada: (1 result)
Sorted by National Drug Code- 59676-600 Erleada 60 mg Oral Tablet, Film Coated by Janssen Products, Lp